logo
episode-header-image
Aug 2024
44m 46s

Market Rally Aims for “Cloud Nine,” Bron...

CNBC
About this episode
Carl Quintanilla and Jim Cramer led off the show by delving into the broadening market rally, as the S&P 500 and Nasdaq aim for a ninth consecutive day of gains. David Faber called into the show with reporting on Edgar Bronfman's bid to acquire Paramount Global. Eli Lilly CEO David Ricks joined the program "First on CNBC"  to discuss the pharma giant’s weigh ... Show More
Up next
Aug 21
11AM Hour: Anthropic Investor on Upcoming IPO, Owner of Rare Trading Card & Crypto's Rally 8/21/26
Early Anthropic investor Matt Murphy shares his expectations ahead of the highly anticipated IPO. Then, we speak to the owner of a rare trading card of Dallas Mavericks star Cooper Flagg, which is expected to sell for more than $5 million. Plus, we break down what's behind the ra ... Show More
44m 5s
Aug 21
10AM Hour: Jefferies Chief Market Strategist, Investing in AI & Manhattan Rents Surge 8/21/26
Jefferies Chief Market Strategist David Zervos joins to discuss the bond market moves this week. Then, Wellington Management's Matt Witheiler shares where he sees opportunity in the AI space right now. Plus, we discuss what's driving the surge in Manhattan rents this year. Squawk ... Show More
42m 22s
Aug 21
9AM Hour: Stocks and Bessent After the Sell-Off, Oil Prices and the Trump Effect, Walmart Price Target Cut Parade 8/21/26
One day after the worst session for the Dow and S&P 500 since late July, Carl Quintanilla, David Faber and Sara Eisen discussed stocks rebounding as Treasury Secretary Bessent's push to lower bond yields remains in focus. RBC Capital's Helima Croft joined the program to talk abou ... Show More
41m 34s
Recommended Episodes
Apr 2025
ICYMI: Eli Lilly's New Weight Loss Pill
Shares in Eli Lilly surged on Friday  after its experimental pill helped patients shed weight and control blood sugar about as well as Ozempic, an advance that could turbocharge what’s already one of the fastest growing markets in medicine. Shares of the drug’s originator Chugai ... Show More
7m 16s
Mar 2025
Stocks Surge To Start Week… And Structure Therapeutics CEO On Weight Loss Space 3/24/25
<p>Stocks jumping to start the week, as investors hope President Trump may be softening his stance on tariffs. If you can believe the bounce, and the sectors seeing the biggest gains. Plus One pharma company looking to tip the scales in the weight loss drug space. What the CEO of ... Show More
43m 45s
Sep 2020
Eli Lilly CEO, Coca Cola CEO & Albertsons CEO
<p>The Dow was down 942 points at its session lows in a September-style selloff to start the week and Jim Cramer is helping investors navigate the day’s volatility. Then, as pharmaceutical companies focus on COVID-19, Eli Lilly CEO Dave Ricks checks in to discuss the company's pr ... Show More
46m 19s
Jun 2024
Apple’s Record High… And Structure Therapeutics’ CEO On Weight Loss Drugs 6/11/24
<p>Shares of Apple jumping to record highs just a day after falling flat on its new AI announcements. The turnaround for the tech titan, and what it means for the market. Plus The weight loss wars rage on… and we’re honing in on oral version of GLP-1’s. How one pharma stock is fa ... Show More
43m 43s
Oct 2025
More Big Tech Results… And Dissecting The Latest Pharma Moves 10/30/25
<p>Apple & Amazon the latest big tech names to report results. The headlines from the company conference calls, and what top tech analyst Gene Munster sees in store for the group. Plus Eli Lilly jumping as its obesity drug sales soar. How the company is moving the needle in the w ... Show More
43m 58s
Jun 2022
Goodyear CEO, David Faber & Souring On Sweetgreen? 06/21/22
The Dow surged over 600 points, with the S&P and Nasdaq also rising, and Jim Cramer is bringing you up to speed on the market action that drove the indices higher. First, Goodyear CEO Richard Kramer joins CNBC's Cramer to talk about the company's latest innovations, supply chain ... Show More
44m 5s
Sep 2025
Novo Dips, AB Foods Slumps, Inditex Climbs
On this episode of Stock Movers: - Novo Nordisk will slash 9,000 jobs globally and cut its profit forecast for the third time this year as it fights to recover ground lost to its more efficient rival Eli Lilly & Co. in the booming obesity drug market. - Associated British Foods s ... Show More
4m 6s